Relation between plasma trough concentration of abiraterone and prostate-specific antigen response in metastatic castration-resistant prostate cancer patients

Auteurs

E. Carton, G. Noe, O. Huillard, L. Golmard, J. Giroux, A. Cessot, N.E.B. Saidu, M. Peyromaure, M. Zerbib, C. Narjoz, J. Guibourdenche, A. Thomas, M. Vidal, F. Goldwasser, B. Blanchet, J. Alexandre